Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 425

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 425
---
monthperiod ended December 31, 2024, these expenditures were not capitalized. As outlined in the research and development expenses section, the increase in R&D costs was driven by outsourced third -partyservices for platform enhancements, and functional upgrades, as well as increased personnel expenses. However, these activities did not meet the capitalization criteria under IFRS and, in accordance with applicable accounting standards, were recorded as expenses, resulting in no capitalized intangible asset additions during the period. Net cash generated from financing activities Net cash generated from financing activities decreased by $80,023, or 9.3%, from $857,149 for the six months ended December31, 2023, to $777,126 for the six months ended December31, 2024. This decrease was primarily driven by: (i)higher payments on principal and interest on debts (increase of outflows $795,679); (ii)partially offset by a) higher cash proceeds from financial liabilities with third and related parties (increase of inflows $540,189); and b) a capital increase arising from cash contribution ($101,934 in the six -monthsperiod ended December31, 2024) and expenses paid by the Parent company on behalf of OmnigenicsAI ($214,443 during the six -monthsperiod ended December31, 2024 versus $140,910 during the six -monthsperiod ended December31, 2023), recognized as additional shareholder contributions (increase of inflows $175,467). Net cash generated from financing activities increased by $67,698, or 3.6%, from $1,867,214 for the year ended June 30, 2023, to $1,934,912 for the year ended June 30, 2024, primarily due to financing inflows from loans provided by shareholders and related parties in the year ended June 30, 2024, resulting from increased borrowings with third parties. Trend Information Please refer to “ — Key Factors Affecting Operating Results.” Off-Balance Sheet Arrangements The Company does not have any off -balancesheet arrangements. Quantitative and Qualitative Disclosures About Market Risk We are exposed to a variety of risks in the ordinary course of our business. These risks primarily include credit risk, liquidity risk and foreign currency risk. For more information about financial risks to which the Company is exposed, see note 3 to the Company’s audited combined financial statements included elsewhere in this proxy statement/prospectus. Credit